Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Merck says EU approves fertility drug Elonva 3:41 PM 1/28/2010
Forbes
Merck and Co received clearance to market its fertility drug Elonva a
single injection intended to help women ovulate.
...
FDA
extends date for Sepracor drug candidate 6:56 AM 1/28/2010
Boston Globe
The US FDA anticipates completing its review of Sepracor Inc's
Stedesa on April 30 as an adjunctive therapy in the treatment of partial-onset seizures in adults with
epilepsy.
...
Otsuka
Hldgs to go public by summer 5:21 AM 1/28/2010
Reuters
Otsuka Holdings Co Ltd is preparing to conduct an initial public offering. The deal
would make the company the fourth-largest in the Japanese pharmaceuticals sector.
...
Pfizer
trims drug pipeline after Wyeth merger 2:36 PM 1/27/2010
Reuters
Pfizer Inc has cut more than 15 percent of its combined drug development programs
following the recent merger with Wyeth.
...
Spectrum
to end development of enlarged-prostate drug 11:39 AM 1/27/2010
Reuters
Spectrum Pharmaceuticals Inc will stop developing its experimental
Ozarelix treatment for enlarged prostate to cut costs and focus on other drug candidates.
...
EpiCept's
pain drug gets orphan drug status 10:09 AM 1/27/2010
Reuters
EpiCept Corp's experimental neuropathic pain drug received orphan drug status from
the US FDA.
...
Court
rules for Teva in Merck cancer drug suit 3:24 PM 1/26/2010
BusinessWeek
A US District Court ruled that a patent on Merck & Co's
chemotherapy drug Temodar (temozolomide) is unenforceable which clears the way for Teva Pharmaceutical
Industries Ltd to sell a generic.
...
J&J
Heated Catheter Better Than Drugs for Irregular
Heartbeats 2:34 PM 1/26/2010
Bloomberg
Johnson & Johnson’s Navistar ThermoCool catheter works better than drugs to
control irregular heartbeats in people not responding to at least one drug.
...
Novo
Nordisk's Victoza Gets US Approval 5:27 AM 1/26/2010
Wall Street Journal
Danish pharmaceutical company Novo Nordisk's drug Victoza for treatment
of type-2 diabetes received US FDA marketing approval with a warning for thyroid cancer.
...
Cephalon
Sues Novartis To Block Generic Nuvigil Drug 2:34 PM 1/25/2010
Wall Street Journal
Cephalon Inc has filed a patent-infringement lawsuit
against a unit of Novartis to block it from selling a generic version of Cephalon's narcolepsy drug Nuvigil.
...
Alternative
prostate cancer vaccine shows promise 2:33 PM 1/25/2010
Reuters
The vaccine Prostvac-VF being developed by BN ImmunoTherapeutics helped patients
with advanced and otherwise untreatable cancer live longer.
...
Abbott
sues Teva over Simcor patents 12:28 PM 1/25/2010
Reuters
Abbott Laboratories asked a federal court to block Teva Pharmaceutical Industries
Ltd from making a generic version of Abbott's Simcor (niacin extended-release/simvastatin) cholesterol
treatment.
...
FDA
clears MS drug co-owned by Biogen Idec 12:09 PM 1/25/2010
Bizjournals.com
Ampyra is the first drug to be US FDA approved to improve walking in
multiple sclerosis patients. It will be marketed by Acorda Therapeutics in the US and Biogen Idec elsewhere.
...
Keryx
cancer drug improves survival in mid-stage trial 8:47 AM 1/25/2010
Reuters
Keryx Biopharmaceuticals Inc's mid-stage trial showed colon cancer drug
KRX-0401 (perifosine) improved overall survival in patients with advanced metastatic colon cancer.
...
Spectrum
says FDA asks for more data on cancer drug 6:04 AM 1/25/2010
Reuters
The US FDA has asked Spectrum Pharmaceuticals Inc for additional data
on its experimental Fusilev (levoleucovorin) treatment for advanced metastatic colorectal cancer. Fusilev is
already approved in patients with osteosarcoma.
...
<- Day Earlier | Today's News
|
